Finally, we showed that expression of the AD risk gene of strongest effect, APOE4, explains downregulation of the expression of NO synthase expression in EC, consistent with a previously proposed mechanism for reduced CBF and impaired neurovascular coupling in AD71. This evidence concerns the gene APOE and Alzheimer disease.